Invicta Diagnostic H1 FY27 Results and Acquisition Deferral
Invicta Diagnostic Ltd · Outcome · 15 Nov 2026, 3:34 am
Invicta Diagnostic H1 FY27 Results and Acquisition Deferral Invicta Diagnostic reported consolidated revenue from operations of ₹2,424.65 lakhs for the half year ended 30th Sep'26, up 43.1% YoY from ₹1,694.73 lakhs. Consolidated net profit stood at ₹232.14 lakhs compared to ₹408.41 lakhs in the previous corresponding period, with basic EPS at ₹2.01. Standalone revenue reached ₹1,379.11 lakhs with a net profit of ₹388.40 lakhs. Additionally, the Board deferred the acquisition proposal for diagnostic centre businesses in Nashik via a subsidiary to a separate meeting.
Original exchange filing (PDF)
More announcements from Invicta Diagnostic Ltd
- Invicta Diagnostic Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- INVICTA DIAGNOSTIC LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Invicta Diagnostic Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 19, 2026. Further, the company has informed the Exchange regarding voting results. · 20 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 19, 2026 · 20 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on September 18, 2026 wherein Board considered and approved the proposed business outlook and forward-looking guidance to be communicated by the Chairman & Managing Director and Chief Financial Officer to the Members at the Company s 3rd Annual General Meeting scheduled to be held on Saturday, 19th September, 2026. · 18 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange about Commencement of commercial operations of Centres at Shegaon Diagnostic LLP (a Subsidiary LLP), and Porteus Pathogenius LLP (a Step-Down Subsidiary LLP) · 17 Sept 2026
- Invicta Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of AGM Notice · 28 Aug 2026
